Sort
261,768 grants matching “gene therapy”
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$951,181Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$951,173Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
$951,144Francis W. Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$951,000Sanford D Markowitz · Case Western Reserve University · R35 · FY2017 · CA
A New Target for Chromatin Remodeler Defects in Cancer
$950,996Cheryl L Walker · Baylor College Of Medicine · R35 · FY2021 · CA
A New Target for Chromatin Remodeler Defects in Cancer
$950,993Cheryl L Walker · Baylor College Of Medicine · R35 · FY2020 · CA
GENE THERAPY STRATEGIES FOR SICKLE CELL DISEASE
$950,962University Of California San Francisco · P01 · FY2000 · HL
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$950,729Jonah B. Sacha · Oregon Health & Science University · R01 · FY2021 · AI
Informative Clinical Studies in Asthma
$950,576Brigham And Women'S Hospital · U10 · FY2003 · HL
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$950,528Joel S. Bader · Johns Hopkins University · U01 · FY2019 · CA
Investigating the heterogeneity and coordination of hematopoietic stem cells
$950,481Rong Lu · University Of Southern California · R35 · FY2020 · HL
T Cell Regulation of Low-Grade Glioma
$950,428David H. Gutmann · Washington University · R01 · FY2025 · CA
Ambient light activatable opsin based therapy for age-related macular degeneration
$950,373Samarendra Kumar Mohanty · Nanoscope Technologies, Llc · R44 · FY2019 · EY
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
$950,348Michael T Lewis · University Of Utah · U54 · FY2017 · CA
Biological Basis of Mental Retardation
$950,326Nancy B Schwartz · University Of Chicago · P01 · FY2015 · HD
Antibody-based Protection against Flavivirses
$950,300Michael S. Diamond · Washington University · R01 · FY2022 · AI
Targeted vaccines against pulmonary NTM infections in vulnerable populations
$950,092Rhea N Coler · Seattle Children'S Hospital · R01 · FY2025 · AI
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$950,045Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Etiological Studies of Gastric Carcinoma
$950,043Louisiana State Univ Hsc New Orleans · P01 · FY2003 · CA
Clinical Trials Network, Ohio Valley Node
$950,000Eugene C. Somoza · University Of Cincinnati · U10 · FY2007 · DA
NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine
$949,949Susan M Knoblach · Children'S Research Institute · R24 · FY2014 · HD
Novel Strategies for Brain Tumor Therapy
$949,875Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · NS
Predicting pancreatic cancer responses for a Parp inhibitor-based clinical trial
$949,858Michael G. Goggins · Johns Hopkins University · RC2 · FY2009 · CA
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$949,793Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Next Generation Smart Nanoparticles
$949,761Jianghong Rao · Stanford University · U54 · FY2013 · CA